Search Results
Arriving at a time of crisis in the diagnostic, explanatory and treatment systems in psychiatry (and therefore also of its profitability) ( Rose, 2016 ), psychedelic substances are slowly proving their capacity to respond to the need for new
cultural, geographic and religious categories ( Hood, 2006 ; Stace, 1960 ). Psychedelics are capable of reliably triggering mystical experiences under carefully orchestrated conditions which appear similar to experiences occurring spontaneously ( Griffiths
) Introduction In philosophy and psychology, there exists a more than a century-old history of psychedelic self-experiments. Both in psychology and philosophy, it was James ( 1882 , 1902/2009 ) who, back in the 1880s, acted as a pioneer when it came to
“The mind was primarily concerned, not with measures and locations, but with being and meaning.” ( Huxley, 1963 , p. 20) Introduction A growing body of evidence supports the use of psychedelic medicines to treat mental illnesses, including PTSD ( De
. Ellis 2022, personal communication, 8 September) Introduction Classic psychedelics, including lysergic acid diethylamide (LSD), psilocybin (the psychoactive compound in magic mushrooms), and mescaline (the psychoactive compound in the peyote and San
Introduction Numerous empirical studies have demonstrated that classic psychedelics, including lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), and mescaline (peyote), are safe and of high therapeutic use for treating mental health
. With the uptake of psychedelics in clinical practice we are seeing what is being termed a ‘psychedelic renaissance’. Critical theorists are only beginning to consider what the psychedelic revolution, and its clinical uptake, imply for the alienating
Introduction Microdosing psychedelics (hereafter referred to as microdosing) refers to the practice of using serotonergic hallucinogens, also known as psychedelics, by repeatedly ingesting doses that do not reach the threshold for perceptual
Introduction Classical or serotonergic psychedelic compounds are a subclass of psychedelic compounds whose method of action is strongly tied to the neurotransmitter serotonin, with the compounds acting as partial agonists at
that nurture an individual's recovery capital can lead to sustained positive outcomes, including abstinence ( Köpetz et al., 2013 ; Laudet & White, 2008 ; Palmer et al., 2009 ). One such re-emerging approach is psychedelic-assisted psychotherapy
